Hydrogen-rich saline reduces cell death through inhibition of DNA oxidative stress and overactivation of poly (ADP-ribose) polymerase-1 in retinal ischemia-reperfusion injury.
Hongwei Liu, Ning Hua, Keliang Xie, Tingting Zhao, Yonghao Yu · Molecular medicine reports · 2015
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
The results demonstrated that HRS administration improved morphological alterations and reduced apoptosis following RIR injury. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in rats. The results demonstrated that HRS administration improved morphological alterations and reduced apoptosis following RIR injury.
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
As molecular hydrogen can easily diffuse into tissues and penetrate the cellular membrane, HRS (5 ml/kg) was injected peritoneally only at the beginning of reperfusion. The results demonstrated that HRS administration improved morphological alterations and reduced apoptosis following RIR injury. The authors concluded that this result was in accordance with the results of the study by Oharazawa et al in which hydrogen loaded eyedrops reduced TUNEL positive cells in nuclear layers of an RIR model ( 42 ). By contrast, the immunoreactivity of 8-OHdG decreased significantly in the GCL immediately following HRS intervention in IR injury, which may confirm the reductive potential of hydrogen to DNA oxidative stress. DNA oxidation was significantly reduced following administration of HRS, demonstrating that molecular hydrogen successfully rescued cells by preventing DNA oxidative breaks.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.